TwinBeech Capital’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-253,795
| Closed | -$3.9M | – | 582 |
|
|
2024
Q3 | $3.9M | Buy |
+253,795
| New | +$3.9M | 0.07% | 296 |
|
|
2024
Q2 | – | Sell |
-142,496
| Closed | -$2.63M | – | 498 |
|
|
2024
Q1 | $2.63M | Buy |
+142,496
| New | +$2.63M | 0.05% | 303 |
|
|
2023
Q4 | – | Sell |
-316,555
| Closed | -$6.6M | – | 615 |
|
|
2023
Q3 | $6.6M | Buy |
316,555
+121,058
| +62% | +$2.52M | 0.13% | 217 |
|
|
2023
Q2 | $4.68M | Buy |
195,497
+79,798
| +69% | +$1.91M | 0.09% | 246 |
|
|
2023
Q1 | $2.18M | Buy |
+115,699
| New | +$2.18M | 0.04% | 359 |
|
|
2022
Q3 | – | Sell |
-79,579
| Closed | -$1.12M | – | 591 |
|
|
2022
Q2 | $1.12M | Buy |
+79,579
| New | +$1.12M | 0.05% | 307 |
|
|
2022
Q1 | – | Sell |
-21,366
| Closed | -$499K | – | 471 |
|
|
2021
Q4 | $499K | Buy |
+21,366
| New | +$499K | 0.03% | 423 |
|
|
2021
Q2 | – | Sell |
-29,975
| Closed | -$773K | – | 424 |
|
|
2021
Q1 | $773K | Buy |
29,975
+25,941
| +643% | +$669K | 0.11% | 229 |
|
|
2020
Q4 | $216K | Sell |
4,034
-14,253
| -78% | -$763K | 0.04% | 403 |
|
|
2020
Q3 | $754K | Buy |
+18,287
| New | +$754K | 0.16% | 192 |
|